Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Point-of-Care Testing
FDA LDT oversight battle: Are we close?
By
Liz Carey
New directions in laboratory developed test (LDT) regulation appeared closer to final rule-making with the March 1 Office of Management and Budget (OMB) acceptance of the LDT final rule, pending regulatory review: a flurry of final rule-making thoughts.
March 6, 2024
Quest Diagnostics seeks to get a jump on PFAS testing in communities
By
Liz Carey
Researchers often use people’s blood PFAS levels as a proxy for exposure to perfluoroalkyl and polyfluoroalkyl substances, the "forever chemicals" found in certain products and the environment.
February 13, 2024
Roche signs $350M deal to buy POC technology from LumiraDx
By
LabPulse.com staff writers
Roche has entered into a definitive agreement to purchase point-of care (POC) technologies from LumiraDx for $295 million, with an additional payment of up to $55 million to fund the POC diagnostics platform business until the transaction closes.
January 3, 2024
Quest Diagnostics launches test panel for novel psychoactive substances
By
LabPulse.com staff writers
The new "confirmatory testing service" will use definitive liquid chromatography with advanced tandem mass spectrometry-based testing to establish NPS misuse.
December 19, 2023
FDA plans to increase oversight of LDTs garner strong response
By
Nick Paul Taylor
Plans to increase U.S. Food and Drug Administration (FDA) oversight of laboratory-developed tests (LDTs) have drawn a strong response from trade groups, individuals, and organizations.
November 17, 2023
Talis Biomedical to lay off 90% of workforce, pursue strategic alternatives
By
LabPulse.com staff writers
POC testing company Talis Biomedical has announced that it will lay off 90% of its employees and has begun exploring strategic alternatives.
November 15, 2023
Polygenic risk score tests don’t meet expectations, U.K. study shows
By
Matt Limb
Polygenic risk scores “perform poorly in screening and prediction of common disease,” failing to identify nearly 90% of patients who develop disease, according to a U.K. study.
October 26, 2023
U.K. researchers recommend routine diabetes screening in EDs
By
Matt Limb
Diabetes screening should be introduced for patients attending hospital emergency departments (EDs) to prompt earlier treatment where necessary and reduce major health risks, say researchers.
October 10, 2023
U.S. government investing $600M in COVID-19 test manufacturing
By
LabPulse.com staff writers
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Some emergency sepsis screening tools inadequate, EU study suggests
By
Matt Limb
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Researchers create low-cost, eco-friendly COVID-19 test
By
Matt Limb
Scientists say they have engineered an accurate, low-cost, and eco-friendly COVID-19 test that could dramatically reduce environmental waste.
September 12, 2023
Researchers develop at-home device for diagnosing gingivitis
By
LabPulse.com staff writers
Researchers at the University of Cincinnati in Ohio are developing a device people can use at home to diagnose gingivitis.
September 12, 2023
Page 1 of 40
Next Page